Coxsackie A2, A7, B1, B3, B5
Coxsackie A2, A7, B1, B3, B5 · HUMAN COXSACKIEVIRUS A2 250 [hp_C]/mL; HUMAN COXSACKIEVIRUS A7 250 [hp_C]/mL; HUMAN COXSACKIEVIRUS B1 250 [hp_C]/mL; HUMAN COXSACKIEVIRUS B3 250 [hp_C]/mL; HUMAN COXSACKIEVIRUS B5 250 [hp_C]/mL · Liquid · Deseret Biologicals, Inc.
NDC 43742-2075-01 · 960 mL in 1 BOTTLE, PLASTIC · DRUG FOR FURTHER PROCESSING · View full market →
Bulk ingredient — not a finished product
This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.
Medicare Part D
This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Coxsackie A2, A7, B1, B3, B5 (Liquid)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Deseret Biologicals, Inc. | HUMAN COXSACKIEVIRUS A2 100 [hp_C]/mL; HUMAN COXSACKIEVIRUS A7 100 [hp_C]/mL; HUMAN COXSACKIEVIRUS B1 100 [hp_C]/mL; HUMAN COXSACKIEVIRUS B3 100 [hp_C]/mL; HUMAN COXSACKIEVIRUS B5 100 [hp_C]/mL | Jul 15, 2026 | Sep 2, 2026 |
| Deseret Biologicals, Inc. | HUMAN COXSACKIEVIRUS A2 15 [hp_C]/mL; HUMAN COXSACKIEVIRUS A7 15 [hp_C]/mL; HUMAN COXSACKIEVIRUS B1 15 [hp_C]/mL; HUMAN COXSACKIEVIRUS B3 15 [hp_C]/mL; HUMAN COXSACKIEVIRUS B5 15 [hp_C]/mL | Jul 15, 2026 | Sep 2, 2026 |
| Deseret Biologicals, Inc. | HUMAN COXSACKIEVIRUS A2 250 [hp_C]/mL; HUMAN COXSACKIEVIRUS A7 250 [hp_C]/mL; HUMAN COXSACKIEVIRUS B1 250 [hp_C]/mL; HUMAN COXSACKIEVIRUS B3 250 [hp_C]/mL; HUMAN COXSACKIEVIRUS B5 250 [hp_C]/mL | Jul 15, 2026 | Sep 2, 2026 |
| Deseret Biologicals, Inc. | HUMAN COXSACKIEVIRUS A2 500 [hp_C]/mL; HUMAN COXSACKIEVIRUS A7 500 [hp_C]/mL; HUMAN COXSACKIEVIRUS B1 500 [hp_C]/mL; HUMAN COXSACKIEVIRUS B3 500 [hp_C]/mL; HUMAN COXSACKIEVIRUS B5 500 [hp_C]/mL | Jul 15, 2026 | Sep 2, 2026 |
| Deseret Biologicals, Inc. | HUMAN COXSACKIEVIRUS A2 7 [hp_C]/mL; HUMAN COXSACKIEVIRUS A7 7 [hp_C]/mL; HUMAN COXSACKIEVIRUS B1 7 [hp_C]/mL; HUMAN COXSACKIEVIRUS B3 7 [hp_C]/mL; HUMAN COXSACKIEVIRUS B5 7 [hp_C]/mL | Jul 15, 2026 | Sep 2, 2026 |
| Deseret Biologicals, Inc. | HUMAN COXSACKIEVIRUS A2 75 [hp_C]/mL; HUMAN COXSACKIEVIRUS A7 75 [hp_C]/mL; HUMAN COXSACKIEVIRUS B1 75 [hp_C]/mL; HUMAN COXSACKIEVIRUS B3 75 [hp_C]/mL; HUMAN COXSACKIEVIRUS B5 75 [hp_C]/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Coxsackie A2, A7, B1, B3, B5 — NDC 43742-2075-01," retrieved September 3, 2026, https://drugdashboards.com/drug/43742207501.
Free to cite with attribution — see how the data is put together.